NCT06546189View on ClinicalTrials.gov

Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

October 1, 2027

Conditions
Overactive Bladder Syndrome
Interventions
DIETARY_SUPPLEMENT

OMNi BiOTiC® 41167

"The product OMNi BiOTiC® 41167 contains lactobacillus strains"

OTHER

Placebo

Placebo

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER